These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16283420)

  • 21. Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patients.
    Derganova O; Martinez-Gamboa L; Egerer K; Bang H; Fredenhagen G; Roggenbuck D; Esaulenko I; Burmester GR; Chernykh T; Feist E
    Clin Exp Rheumatol; 2014; 32(5):622-9. PubMed ID: 25189876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-cyclic citrullinated peptide in preclinical rheumatoid arthritis. Food for thought.
    Ménard HA
    J Rheumatol; 2009 Apr; 36(4):663-4. PubMed ID: 19342718
    [No Abstract]   [Full Text] [Related]  

  • 23. Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review.
    Lee AN; Beck CE; Hall M
    Clin Lab Sci; 2008; 21(1):15-8. PubMed ID: 18335856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis.
    Aggarwal R; Liao K; Nair R; Ringold S; Costenbader KH
    Arthritis Rheum; 2009 Nov; 61(11):1472-83. PubMed ID: 19877103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-cyclic citrullinated peptide antibodies in the diagnosis of rheumatoid arthritis: bayes clears the haze.
    Finckh A; Liang MH
    Ann Intern Med; 2007 Jun; 146(11):816-7. PubMed ID: 17548414
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immune diagnostics in rheumatology].
    Gruber R; Borgmann S
    Z Rheumatol; 2014 Aug; 73(6):541-52; quiz 553-5. PubMed ID: 25096587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticyclic citrullinated peptide antibody-negative rheumatoid arthritis: clues to disease pathogenesis.
    Crow MK
    Curr Rheumatol Rep; 2008 Jul; 10(3):165-7. PubMed ID: 18638423
    [No Abstract]   [Full Text] [Related]  

  • 28. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
    J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The fibrin-derived citrullinated peptide β60-74Cit₆₀,₇₂,₇₄ bears the major ACPA epitope recognised by the rheumatoid arthritis-specific anticitrullinated fibrinogen autoantibodies and anti-CCP2 antibodies.
    Cornillet M; Sebbag M; Verrouil E; Magyar A; Babos F; Ruyssen-Witrand A; Hudecz F; Cantagrel A; Serre G; Nogueira L
    Ann Rheum Dis; 2014 Jun; 73(6):1246-52. PubMed ID: 23636655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can we rely on anti-citrulline antibody determination for the diagnosis of early rheumatoid arthritis?
    Bell DA
    J Rheumatol; 2006 Dec; 33(12):2369-71. PubMed ID: 17143974
    [No Abstract]   [Full Text] [Related]  

  • 31. [Usefulness of anti-citrullinated protein antibodies in the diagnosis and prognosis of rheumatoid arthritis].
    Bas S
    Rev Med Suisse; 2005 Mar; 1(10):674, 677-8, 680 passim. PubMed ID: 15828370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Early diagnosis of rheumatoid arthritis with a test based upon a specific antigen: cyclic citrullinated peptide].
    Jansen TL
    Ned Tijdschr Geneeskd; 2003 Apr; 147(15):729-30; author reply 730-1. PubMed ID: 12722537
    [No Abstract]   [Full Text] [Related]  

  • 33. Anti-cyclic citrullinated peptide testing for the diagnosis of rheumatoid arthritis and the quest for improved sensitivity and predictive value.
    Levesque MC; Zhou Z; Moreland LW
    Arthritis Rheum; 2009 Aug; 60(8):2211-5. PubMed ID: 19644881
    [No Abstract]   [Full Text] [Related]  

  • 34. Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis?
    Girelli F; Foschi FG; Bedeschi E; Calderoni V; Stefanini GF; Martinelli MG
    Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):127-30. PubMed ID: 15180353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-cyclic citrullinated peptide antibody versus HAQ/MDHAQ: comparing apples and oranges?
    Bykerk V
    J Rheumatol; 2009 Aug; 36(8):1565-7. PubMed ID: 19671806
    [No Abstract]   [Full Text] [Related]  

  • 36. [Anti-cyclic citrullinated peptide (CCP) antibodies].
    Mimori T
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():491-4. PubMed ID: 20942111
    [No Abstract]   [Full Text] [Related]  

  • 37. Anti-cyclic citrullinated peptide antibody in early rheumatoid arthritis: comment on the editorial by Scott.
    van Venrooij WJ; van de Putte LB; van den Hoogen FH
    Arthritis Rheum; 2003 Mar; 48(3):857; author reply 857-8. PubMed ID: 12632446
    [No Abstract]   [Full Text] [Related]  

  • 38. Presence and diagnostic performances of IgA class antibodies to mutated citrullinated vimentin in rheumatoid arthritis.
    Sghiri R; Khalifa O; Bouajina E; Ben Haj Slama F; Baccouche K; Ben Fredj H; Gaha R; Boukadida J
    Joint Bone Spine; 2010 May; 77(3):279-80. PubMed ID: 20378382
    [No Abstract]   [Full Text] [Related]  

  • 39. High levels of anti-cyclic citrullinated peptide autoantibodies are associated with co-occurrence of pulmonary diseases with rheumatoid arthritis.
    Aubart F; Crestani B; Nicaise-Roland P; Tubach F; Bollet C; Dawidowicz K; Quintin E; Hayem G; Palazzo E; Meyer O; Chollet-Martin S; Dieudé P
    J Rheumatol; 2011 Jun; 38(6):979-82. PubMed ID: 21362759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.
    Mathsson L; Mullazehi M; Wick MC; Sjöberg O; van Vollenhoven R; Klareskog L; Rönnelid J
    Arthritis Rheum; 2008 Jan; 58(1):36-45. PubMed ID: 18163519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.